Midatech Pharma

OverviewSuggest Edit

Midatech is a world leader in the design, synthesis and manufacture of biocompatible gold nanoparticles (GNPs) with a core focus on therapeutics for diabetes and cancer.
Midatech has a strong pipeline of product candidates in clinical and pre-clinical development for the treatment of diabetes and various cancers. In 2012, Midatech established MidaSol Therapeutics LP, a strategic joint venture with MonoSol Rx LLC to focus on the development and commercialization, via partnering or licensing, of products primarily for the treatment of diabetes. MidaSol’s lead product, Midaform™ Insulin PharmFilm, is a unique product for the oral delivery of insulin in diabetic patients and will enter Phase II clinical studies in 2014. These technologies are also being evaluated in the diabetes area by a major US pharmaceutical company.
Midatech’s unique GNP technology enables the administration and targeted delivery of therapeutic compounds to specific cells and tissues. Multiple drug molecules can be attached to one of its GNPs allowing multivalent drug or multi-drug delivery. The size of the GNPs potentially also enables drug delivery via a variety of different routes of administration, such as oral, parental, transdermal, mucosal, intradermal, transbuccal, sublingual or intranasal/inhalation.
Midatech has exclusive world-wide IP for the technology covering design, manufacture and application of nanoparticles in therapeutic and diagnostic pharmaceutical areas as well as in other industries.
In 2014, Midatech Pharma acquired Q Chip, now Midatech Pharma Wales to support novel delivery platforms and product developments in cancer, diabetes and ophthalmology. Q Chip has developed a complementary technology and products that allow sustained release of substances over extended periods of time and will provide a platform to incorporate Midatech's gold nanoparticle (GNP) compounds for sustained and extended release.

TypePublic
Founded2000
Websitemidatechpharma.com

Latest Updates

Employees (est.) (Jun 2017)84(+14%)
Revenue (FY, 2018)£1.9 M(-74%)

Key People/Management at Midatech Pharma

Nick Robbins-Cherry

Nick Robbins-Cherry

CFO
Daniel Palmer

Daniel Palmer

Chief Scientific Officer
Tom Coulter

Tom Coulter

Head of Chemistry
David Webb

David Webb

VP Manufacturing
Emma Matthews

Emma Matthews

Executive PA and HR Manager
Show more

Midatech Pharma Office Locations

Midatech Pharma has offices in Cardiff and Milton
Cardiff, GB
19 Newport Rd
Milton, GB
Milton Park Innovation Centre, 99 Park Drive
Show all (2)

Midatech Pharma Financials and Metrics

Midatech Pharma Revenue

Midatech Pharma's revenue was reported to be £1.94 m in FY, 2018
GBP

Revenue (FY, 2018)

1.9m

Net income (FY, 2018)

(10.4m)

EBITDA (FY, 2018)

(10.4m)

EBIT (FY, 2018)

(11.8m)

Cash (31-Dec-2018)

2.3m
GBPFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.4m6.9m7.6m1.9m

Revenue growth, %

776%403%10%

Cost of goods sold

70.0k667.0k926.0k

Gross profit

1.3m6.3m6.7m
GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

2.4m30.3m16.2m17.6m13.2m2.3m

Accounts Receivable

160.0k189.0k985.0k1.4m2.2m89.0k

Inventories

459.0k817.0k941.0k

Current Assets

4.1m31.6m20.3m22.3m18.6m5.6m
GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(4.1m)(8.8m)(10.1m)(20.2m)(11.7m)(10.4m)

Cash From Operating Activities

(4.4m)(5.5m)(12.4m)(13.1m)(13.0m)(13.4m)

Cash From Financing Activities

6.7m34.3m(219.0k)15.3m10.3m(6.5m)

Net Change in Cash

2.3m27.9m(14.2m)967.0k(4.1m)(10.9m)
GBPY, 2018

Financial Leverage

1.2 x
Show all financial metrics

Midatech Pharma Operating Metrics

Apr, 2017

Patent Applications

81

Patents Issued

77

Patents and Patent Applications

35
Show all operating metrics

Midatech Pharma Revenue Breakdown

Embed Graph

Midatech Pharma revenue breakdown by business segment: 49.2% from United States, 7.1% from Europe and 43.6% from Grant revenue

Midatech Pharma Online and Social Media Presence

Embed Graph

Midatech Pharma News and Updates

Midatech Pharma US, Inc. Announces Corporate Name Change To Fortovia Therapeutics And Appointment Of New CEO And CFO

RALEIGH, N.C., June 24, 2019 /PRNewswire/ -- Midatech Pharma US, Inc., an oncology supportive care specialty pharmaceutical company dedicated to helping patients manage cancer symptoms and treatment-related side effects, announced today that it has formally changed its name to Fortovia...

Thinking about buying stock in Anadarko Petroleum Corp., Facebook Inc., Microsoft Corp., Midatech Pharma, or New Age Beverages Corp.?

NEW YORK, April 25, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APC, FB, MSFT, MTP, and NBEV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Aceto, Canopy Growth Corp., Frontier Communications Corp., Midatech Pharma or Sea Ltd?

NEW YORK, Feb. 28, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACET, CGC, FTR, MTP, and SE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Aurora Cannabis, FTE Networks, Goodyear Tire & Rubber, Midatech Pharma or NIO?

NEW YORK, Feb. 27, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, FTNW, GT, MTP, and NIO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Midatech Pharma Frequently Asked Questions

  • When was Midatech Pharma founded?

    Midatech Pharma was founded in 2000.

  • Who are Midatech Pharma key executives?

    Midatech Pharma's key executives are Nick Robbins-Cherry, Daniel Palmer and Tom Coulter.

  • How many employees does Midatech Pharma have?

    Midatech Pharma has 84 employees.

  • What is Midatech Pharma revenue?

    Latest Midatech Pharma annual revenue is £1.9 m.

  • What is Midatech Pharma revenue per employee?

    Latest Midatech Pharma revenue per employee is £23.1 k.

  • Who are Midatech Pharma competitors?

    Competitors of Midatech Pharma include Actinium Pharmaceuticals, F-star Biotechnology and Quark Pharmaceuticals.

  • Where are Midatech Pharma offices?

    Midatech Pharma has offices in Cardiff and Milton.

  • How many offices does Midatech Pharma have?

    Midatech Pharma has 2 offices.